CROSSFUND SICAV - Crossinvest Healthcare Fund B USD Fonds
|
WKN DE: A2DHA4 / ISIN: LU1334634612
Anlageziel
The investment objective of the Sub‐Fund is to achieve a long term capital appreciation by pursuing sector focus exposure opportunities in companies involved in health and personal care. These companies could participate in the research, clinical development or commercialization of medicines, equipment or services for disease treatment or life style improvement. The investment focus will be on industry leaders that offer premium growth and/or profitability prospects, pipeline and valuation upside. The Sub‐Fund is actively managed. The Sub‐Fund has no benchmark index and is not managed in reference to a benchmark index.
Stammdaten
WKN | A2DHA4 |
ISIN | LU1334634612 |
Fondsgesellschaft | Crossinvest |
Kategorie | Branchen: Gesundheitswesen |
Währung | USD |
Mindestanlage | |
VL-fähig? | Nein |
Thesaurierend/Ausschüttend | Thesaurierend |
Fondsmanager |
Aktuelle Daten
Fondsnote | - |
Aktueller Rücknahmepreis | 156,84 |
Fondsvolumen | 63 096 999,61 |
Total Expense Ratio (TER) | 2,54 |
Gebühren
Verwaltungsgebühr | % |
Depotbankgebühr | % |
Rücknahmegebühr | 5,00 % |
Ausgabeaufschlag | 5,00 % |
Basisdaten
Auflagedatum | 22.04.2016 |
Depotbank | Pictet & Cie (Europe) SA |
Zahlstelle | |
Domizil | Luxembourg |
Geschäftsjahr | 31.12.2024 |
Performancedaten
Veränderung Vortag | -0,47 |